alendronate has been researched along with Maxillary Diseases in 23 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Maxillary Diseases: Diseases involving the MAXILLA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model." | 7.76 | Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. ( Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A, 2010) |
| "We have found 11 cases of BRONJ in our hospital: 4 women taking oral alendronate or risendronate for osteoporosis and 7 cancer patients treated with intravenous zolendronic acid." | 4.88 | [Bisphosphonate related osteonecrosis of the jaw and infection with Actinomyces]. ( Arranz Caso, JA; Dominguez-Mompello, JL; Flores Ballester, E; López Pizarro, V; Ngo Pombe, S; Restoy Lozano, A, 2012) |
| "The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model." | 3.76 | Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. ( Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A, 2010) |
| "Periodontitis was induced by ligature around the upper second molar in 36 male Wistar rats (± 200 g)." | 1.38 | Effect of alendronate on bone-specific alkaline phosphatase on periodontal bone loss in rats. ( Dutra, CS; Goes, P; Lima, AP; Lima, V; Melo, IM, 2012) |
| " Current reports have focused on therapy-resistant osteonecrosis of the jaws as a possible side effect of bisphosphonates." | 1.33 | [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates]. ( Eufinger, H; Hoefert, S, 2005) |
| "Here we report 29 cases of bone necrosis of the jaws in patients treated with pamidronate (Aredia), zoledronate (Zometa) and alendronate: 15 underwent surgical procedures and 14 occurred spontaneously." | 1.33 | Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. ( Bonaninil, M; Corcione, L; Corradi, D; D'Aleo, P; Ferrari, S; Guidotti, R; Manfredi, M; Meleti, M; Merigo, E; Poli, T; Ripasarti, A; Sesenna, E; Vescovi, P; Zanzucchi, E, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| de Mendonça, RP | 1 |
| Mitre, GP | 1 |
| Real, FH | 1 |
| da Silva Kataoka, MS | 1 |
| de Melo Alves Júnior, S | 1 |
| Vianna, P | 1 |
| Da Silva Júnior, NG | 1 |
| de Jesus Viana Pinheiro, J | 1 |
| Albu, S | 1 |
| López-Cedrún, JL | 1 |
| Sanromán, JF | 1 |
| García, A | 1 |
| Peñarrocha, M | 1 |
| Feijoo, JF | 1 |
| Limeres, J | 1 |
| Diz, P | 1 |
| Ulmner, M | 1 |
| Jarnbring, F | 1 |
| Törring, O | 1 |
| Balint, A | 1 |
| Decoteau, C | 1 |
| Oreadi, D | 1 |
| Lehrer, S | 1 |
| Montazem, A | 1 |
| Ramanathan, L | 1 |
| Pessin-Minsley, M | 1 |
| Pfail, J | 1 |
| Stock, RG | 1 |
| Kogan, R | 1 |
| Barrow, SY | 1 |
| Magliocca, KR | 1 |
| Stavropoulos, MF | 2 |
| Bhattacharyya, I | 2 |
| Cohen, DM | 2 |
| Hoefert, S | 2 |
| Schmitz, I | 1 |
| Tannapfel, A | 1 |
| Eufinger, H | 2 |
| Bocanegra-Pérez, S | 1 |
| Vicente-Barrero, M | 1 |
| Sosa-Henríquez, M | 1 |
| Gebaguer Blanco, A | 1 |
| Knezevic, M | 1 |
| Castellano-Navarro, JM | 1 |
| Treister, NS | 1 |
| Friedland, B | 1 |
| Woo, SB | 1 |
| Chiu, CT | 1 |
| Chiang, WF | 1 |
| Chuang, CY | 1 |
| Chang, SW | 1 |
| Fitzpatrick, SG | 1 |
| Bowers, LM | 1 |
| Neuman, AN | 1 |
| Hinkson, DW | 1 |
| Green, JG | 1 |
| Goes, P | 1 |
| Melo, IM | 1 |
| Dutra, CS | 1 |
| Lima, AP | 1 |
| Lima, V | 1 |
| Arranz Caso, JA | 1 |
| Flores Ballester, E | 1 |
| Ngo Pombe, S | 1 |
| López Pizarro, V | 1 |
| Dominguez-Mompello, JL | 1 |
| Restoy Lozano, A | 1 |
| Price, U | 1 |
| Le, HO | 1 |
| Powell, SE | 1 |
| Schmid, MJ | 1 |
| Marx, DB | 1 |
| Zhang, Y | 1 |
| Wang, D | 1 |
| Narayana, N | 1 |
| Reinhardt, RA | 1 |
| Carter, G | 1 |
| Goss, AN | 1 |
| Doecke, C | 1 |
| Merigo, E | 1 |
| Manfredi, M | 1 |
| Meleti, M | 1 |
| Guidotti, R | 1 |
| Ripasarti, A | 1 |
| Zanzucchi, E | 1 |
| D'Aleo, P | 1 |
| Corradi, D | 1 |
| Corcione, L | 1 |
| Sesenna, E | 1 |
| Ferrari, S | 1 |
| Poli, T | 1 |
| Bonaninil, M | 1 |
| Vescovi, P | 1 |
| Letonturier, P | 1 |
| Levin, L | 1 |
| Laviv, A | 1 |
| Schwartz-Arad, D | 1 |
| Torres, J | 1 |
| Tamimi, F | 1 |
| García, I | 1 |
| Cebrian, JL | 1 |
| López-Cabarcos, E | 1 |
| Lopez, A | 1 |
1 review available for alendronate and Maxillary Diseases
| Article | Year |
|---|---|
[Bisphosphonate related osteonecrosis of the jaw and infection with Actinomyces].
Topics: Actinomyces; Actinomycosis; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Bisphosphon | 2012 |
22 other studies available for alendronate and Maxillary Diseases
| Article | Year |
|---|---|
Central Giant Cell Granuloma Treated with Intralesional Corticosteroid Injections and Bisphosphonates: A Long-Term Follow-Up Case Study.
Topics: Adrenal Cortex Hormones; Alendronate; Anti-Inflammatory Agents; Bone Density Conservation Agents; Ca | 2020 |
Bisphosphonates and osteonecrosis of the maxilla.
Topics: Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; F | 2014 |
Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Alendronate; Bisphosphonate-Associated Osteonec | 2013 |
Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Alendronate; Bisphosphonate-Associated O | 2014 |
A clinico-pathologic correlation.
Topics: Aged; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Age | 2013 |
Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.
Topics: Alendronate; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Collagen Type I; Cysteine | 2009 |
Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Denture, Complete, Upper; Diphosphonates; Femal | 2008 |
A compounded diagnosis: maxillary osteochemonecrosis in the setting of low dose radiotherapy.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Diagnosis, Differential; Diphosphonates; Female | 2009 |
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Di | 2010 |
[Osteonecrosis of the jaw secondary to oral alendronate: Report of three cases].
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; F | 2009 |
Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.
Topics: Adult; Aged; Alendronate; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Diphospho | 2010 |
Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
Topics: Actinomycosis; Administration, Oral; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Bo | 2010 |
Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Topics: Aged; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Age | 2012 |
Effect of alendronate on bone-specific alkaline phosphatase on periodontal bone loss in rats.
Topics: Alendronate; Alkaline Phosphatase; Alveolar Bone Loss; Alveolar Process; Analysis of Variance; Anima | 2012 |
Effects of local simvastatin-alendronate conjugate in preventing periodontitis bone loss.
Topics: Alendronate; Alveolar Bone Loss; Animals; beta-Cyclodextrins; Bone Density Conservation Agents; Drug | 2013 |
Alendronate (Fosamax) and risedronate (Actonel) revisited.
Topics: Alendronate; Bone Density; Bone Remodeling; Dose-Response Relationship, Drug; Etidronic Acid; Female | 2005 |
Bisphosphonates and avascular necrosis of the jaw: a possible association.
Topics: Aged; Aged, 80 and over; Alendronate; Anti-Inflammatory Agents; Diphosphonates; Female; Follow-Up St | 2005 |
[Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].
Topics: Aged; Alendronate; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular D | 2005 |
Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
Topics: Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Antifungal Agents; Bone Density Conserv | 2006 |
[Questions and answers about bisphosphonates].
Topics: Administration, Oral; Age Factors; Alendronate; Bone Density; Bone Density Conservation Agents; Bone | 2007 |
Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment.
Topics: Administration, Oral; Aged; Alendronate; Bone Density Conservation Agents; Denture, Partial, Removab | 2007 |
Management of atrophic maxilla in severe osteoporosis treated with bisphosphonates: a case report.
Topics: Alendronate; Alveolar Bone Loss; Bone Density; Bone Density Conservation Agents; Bone Regeneration; | 2008 |